BenchSci raises $22 million for AI-powered drug discovery tools
February 4, 2020
Assessing the health of pharmaceutical R&D by unearthing hidden patterns in procurement data is a task made simpler by AI. At least, that’s the pitch given by David Qixiang Chen, Elvis Wianda, Liran Belenzon, and Tom Leung, who cofounded BenchSci in 2015. The Toronto, Canada-based biotech company taps AI to run experiments that accelerate drug discovery with the aim of increasing the speed…